The Full ASGCT 27th Annual Meeting Abstracts Collection is NOW LIVE! Click here to read the full collection.
Join us Sept. 26-27 in person in Washington, D.C. or virtually for the fourth annual Policy Summit.
Registration is now open for ASGCT's hybrid Policy Summit Sept. 26-27. Speakers will discuss hot topics that inform policies impacting the field, like PDUFA reauthorization, diversity in clinical trials, accelerated approval, and more.
In-person attendance is extremely limited, so register early to secure your spot in Washington, D.C.!
If you have attended a previous ASGCT event, please sign into your account below. If this is your first time registering for an ASGCT event, you can create an account below.
Monday, Sept. 26, 2022
Supporting Innovative CGT Development
PDUFA Reauthorization (Learn more on our blog)
Keynote Address from John Coster, PhD: Biden Administration Priorities for Medicaid Policy: Implications for Gene and Cell Therapy
Diversity in Cell and Gene Therapy Development
Accelerated Approval
Tuesday, Sept. 27, 2022
Coverage and Reimbursement for Cell and Gene Therapies
CMC Applications and Hurdles for Gene and Cell Therapies
Read the Full Agenda
Any questions? Email advocacy@asgct.org.
May 7-11, 2024 | Baltimore, MD
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico